Adipose tissue NAD(+) biology in obesity and insulin resistance: From mechanism to therapy.
Adipose tissue NAD(+) biology in obesity and insulin resistance: From mechanism to therapy.
复制标题
DOI:
10.1002/bies.201600227
复制
发表时间:
2017-05
期刊:
影响因子:
--
通讯作者:
Yoshino J
中科院分区:
文献类型:
--
作者:
Yamaguchi S;Yoshino J
Nicotinamide adenine dinucleotide (NAD+) biosynthetic pathway, mediated by nicotinamide phosphoribosyltransferase (NAMPT), a key NAD+ biosynthetic enzyme, plays a pivotal role in controlling many biological processes, such as metabolism, circadian rhythm, inflammation, and aging. Over the past decade, NAMPT-mediated NAD+ biosynthesis, together with its key downstream mediator, namely the NAD+-dependent protein deacetylase SIRT1, has been demonstrated to regulate glucose and lipid metabolism in a tissue-dependent manner. These discoveries have provided novel mechanistic and therapeutic insights into obesity and its metabolic complications, such as insulin resistance, an important risk factor for developing type 2 diabetes and cardiovascular disease. This review will focus on the importance of adipose tissue NAMPT-mediated NAD+ biosynthesis and SIRT1 in the pathophysiology of obesity and insulin resistance. We will also critically explore translational and clinical aspects of adipose tissue NAD+ biology.